Peter R. Gilbert
National Institutes of Health
2 Papers
8 Citations
Peter R. Gilbert is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Internal medicine & Randomized controlled trial. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
Andrew McGarry,Michael P. McDermott,Karl Kieburtz,Elisabeth A. deBlieck,Flint Beal,Karen Marder,Christopher A. Ross,Ira Shoulson,Peter R. Gilbert,William Mallonee,Mark Guttman,Joanne Wojcieszek,Rajeev Kumar,Mark S. LeDoux,Mary E. Jenkins,H. Diana Rosas,Martha Nance,Kevin M. Biglan,Peter Como,Richard Dubinsky,Kathleen M. Shannon,Padraig E. O'Suilleabhain,Kelvin L. Chou,Francis O. Walker,W.R. Wayne Martin,Vicki L. Wheelock,Elizabeth McCusker,Joseph Jankovic,Carlos Singer,Juan Sanchez-Ramos,Burton L. Scott,Oksana Suchowersky,Stewart A. Factor,Donald S. Higgins,Eric Molho,Fredy J. Revilla,John N. Caviness,Joseph H. Friedman,Joel S. Perlmutter,Andrew Feigin,Karen E. Anderson,Ramon L. Rodriguez,Nikolaus R. McFarland,Russell L. Margolis,Eric S. Farbman,Lynn A. Raymond,Valerie Suski,Sandra K. Kostyk,Amy Colcher,Lauren Seeberger,Eric A. Epping,Sherali Esmail,Nancy Diaz,Wai Lun Alan Fung,Alan Diamond,Samuel Frank,Philip C. Hanna,Neal Hermanowicz,Leon S. Dure,Merit Cudkowicz +59 more
TL;DR: In this article, the authors performed a multicenter randomized, double-blind, placebo-controlled trial to test the hypothesis that chronic treatment of early-stage Huntington disease with high-dose coenzyme Q10 (CoQ) will slow the progressive functional decline of HD.
112
Clinical trials in children--How are they implemented?
TL;DR: The role and responsibilities of different participants in a trial are discussed, including the steering committee, the clinical and statistical co-ordinating centers, and the data and safety monitoring board, and advantages of external vs internal pilot studies are reviewed.
8